Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1167.7000 -5.20 (-0.44%)
NSE Jan 13, 2026 15:31 PM
Volume: 855.0K
 

logo
Aurobindo Pharma Ltd.
13 Nov 2018, 11:44AM
1167.70
-0.44%
buy
Results Update: Aurobindo Pharma Ltd.
by HDFC Securities
HDFC Securities
Aurobindo Pharma Ltd Q2FY19 results Comment Revenue grew by 11.61% to Rs. 4667.12 Cr in Q2FY19 when compared to the previous quarter. Also, it increased by 7.19% when compared with Q2FY18.
 
Aurobindo Pharma Ltd. is trading above its 200 day SMA of 1145.0
More from Aurobindo Pharma Ltd.
Recommended
Market closes lower, dragged down by foreign investor outflows and mixed earnings
Trendlyne Marketwatch | 13 Jan 2026, 04:07PM
IPO wave continues as Amagi Media and Five SMEs open for subscription
| 12 Jan 2026, 06:40PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020